Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05418933
Other study ID # SKH-111-1
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 10, 2022
Est. completion date August 1, 2022

Study information

Verified date June 2022
Source Taipei Medical University
Contact Ru-Lan Hsieh, MD
Phone 886-2-28332211
Email M001052@ms.skh.org.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To investigate the therapeutic effects of family workshops on children with global developmental delays and their parents by the analysis of the previously conducted workshops.


Description:

To evaluate the effects of family workshops for children aged 18-36 months old with language developmental delays conducted from Jan 2014 Jan to Dec 2018, by the data analysis. The participants were children with global developmental delay (language delay with at least one delay in motor, cognitive function, or emotional and social functioning) and their parents in the workshops. The family workshops were conducted with 5 courses, with 6-7 families in one course, a 2-hour session per week, for 6 weeks. Effects: 1. Investigate the therapeutic effects of workshops for children with global developmental delays 2. Investigate the therapeutic effects of workshops for the parents of children with global developmental delays


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 101
Est. completion date August 1, 2022
Est. primary completion date August 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Months to 36 Months
Eligibility Inclusion Criteria: - Children aged 18-36 months old with global developmental delays (language developmental delay, with motor, cognition, or social and emotional developmental delays) Parents and children attended the one 2 hour-session of workshop per week for 6 weeks Exclusion Criteria: - Less than 18 months old or older than 36 months old

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Family workshop
Family workshops for 5 courses, with 6-7 families in one course. The workshops were 2 hours per session, one time per week, for a total of 6 weeks.

Locations

Country Name City State
Taiwan Shin Kong Wu Ho-Su Memorial Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
Taipei Medical University

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pediatric Outcome Data Collection Instrument measure the functional performance of children, the minimum and maximum values range from 1 to 100, higher scores mean a better outcome scores change of Pediatric Outcome Data Collection Instrument from baseline to 6 weeks after treatment
Secondary Mandarin-Chinese Communicative Developmental Inventory assess communication function of children, <10% indicates delayed development, 10% or more than 10% indicates normal development percent change of Mandarin-Chinese Communicative Developmental Inventory from baseline to 6 weeks after treatment
Secondary Peabody Developmental Motor Scale assess fine motor function of children, the minimum and maximum values range from 1 to 100, higher scores mean a better outcome scores change of Peabody Developmental Motor Scale from baseline to 6 weeks after treatment
Secondary Emotional Competency Rating Scale assess the emotional function of children, the minimum and maximum values range from 1 to 100, higher scores mean a better outcome scores change of Emotional Competency Rating Scale from baseline to 6 weeks after treatment
Secondary Pediatric Evaluation of Disability Inventory assess the functional skill attainment of children, the minimum and maximum values range from 1 to 100, higher scores mean a better outcome scores change of Pediatric Evaluation of Disability Inventory from baseline to 6 weeks after treatment
Secondary Pediatric Daily Occupation Scale assess the occupational performance in the daily life of children, the minimum and maximum values range from 1 to 100, higher scores mean a better outcome scores change Pediatric Daily Occupation Scale from baseline to 6 weeks after treatment
Secondary Pediatric Quality of Life Inventory-Geriatric Core Scale assess the quality of life of children, the minimum and maximum values range from 1 to 100, higher scores mean a better outcome scores change ofPediatric Quality of Life Inventory-Geriatric Core Scale from baseline to 6 weeks after treatment
Secondary Pediatric Quality of Life Inventory-Family Impact Module assess the impact of pediatric conditions on family functioning and parental quality of life, the minimum and maximum values range from 1 to 100, higher scores mean a better outcome scores change of Pediatric Quality of Life Inventory-Family Impact Module from baseline to 6 weeks after treatment
Secondary Parental satisfaction questionnaire assess the parents' satisfaction with the workshops, with scores ranging from 1-to 100, higher scores mean a higher satisfaction scores of Parental satisfaction questionnaire after treatment
Secondary Caregiver Strain Index assess family strain, the minimum and maximum values range from 1 to 100, higher scores mean a worse outcome scores change of Caregiver Strain Index from baseline to 6 weeks after treatment
See also
  Status Clinical Trial Phase
Completed NCT04511767 - Reliability and Validity of CCISO for Diagnosis of Autism Spectrum Disorder
Completed NCT01430845 - Predicting Developmental Disability Type and Mental Retardation Level in Children With General Developmental Delay
Completed NCT05408351 - The Indonesian Version of Ages and Stages Questionnaire III Accuracy Compared to Bayley Scales of Infant Development III
Completed NCT01601158 - Umbilical Cord Blood Therapy for Children With Global Developmental Delay N/A
Completed NCT03847402 - The Early Integrated Intervention for Child Brain-developmental Disorders in China N/A
Completed NCT01441674 - Animal Assisted Therapy in a Pediatric Setting Phase 1/Phase 2
Completed NCT01769716 - Umbilical Cord Blood Therapy for Global Developmental Delay N/A
Recruiting NCT05879952 - Virtual Reality and Neuropsychiatric Rehabilitation in Patients With Global Developmental Delay. N/A
Completed NCT04816175 - Intensive Therapy for Children With Microcephaly, Hyperkinetic Movements, or Global Developmental Delay N/A
Completed NCT05398900 - Validity and Reliability of Indonesian Translated Ages and Stages Questionnaires - Third Edition (ASQ-3) as a Screening Tool for Developmental Delay in 1-12 Months Old Children